Skip to main content
SpringerLink
Log in

Reproducibility of the Bath Ankylosing Spondylitis Indices of disease activity (BASDAI), functional status (BASFI) and overall well-being (BAS-G) in anti-tumour necrosis factor-treated spondyloarthropathy patients

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Function Index (BASFI) and the Bath Ankylosing Spondylitis Global Score (BAS-G) (ranges 0–10) have gained widespread in use as self-reported measures of disease activity, functional impairment and overall well-being in patients with ankylosing spondylitis and other spondyloarthropathies (SpA). In Denmark, BASDAI, BASFI and BAS-G are systematically used to monitor treatment response in patients treated with tumour necrosis factor (TNF) inhibitors. The purpose of the present study was to examine the reproducibility of the indices in anti-TNF-treated SpA patients already familiar with the use of the indices. Testing was performed twice on two different days (median interval 7 days, range 4–10 days) under standardised conditions in 26 out-clinic patients (median age 39 years, range 22–56 years). Limits of agreement were calculated as the 95% likely range for the difference between paired scores. Test–retest results were significantly intercorrelated with r s = 0.90 for BASDAI, 0.92 for BASFI and 0.74 for BAS-G. Limits of agreement for BASDAI, BASFI and BAS-G were ±1.8, ±1.4 and ±3.2, respectively. Reproducibility as expressed as the mean of individual standard deviations was significantly poorer for BAS-G than for BASDAI and BASFI (p < 0.01). Internal consistency reliability and construct validity of BASDAI and BASFI were acceptable. In conclusion, in a sample of anti-TNF-treated patients experienced with the use of BASDAI, BASFI and BAS-G, random measurement errors of the scores were not negligible. The finding should be considered when monitoring anti-TNF treatment in daily clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zochling J, Braun J (2007) Assessments in ankylosing spondylitis. Best Pract Res Clin Rheumatol 21:699–712

    Article  PubMed  Google Scholar 

  2. Ward MM (1998) Quality of life in patients with ankylosing spondylitis. Rheum Dis Clin North Am 24:815–827

    Article  CAS  PubMed  Google Scholar 

  3. Garrett S, Jenkinson T, Keenedy G et al (1994) A new approach to evaluate to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1:2286–2291

    Google Scholar 

  4. Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285

    CAS  PubMed  Google Scholar 

  5. Jones SD, Steiner A, Garrett SL et al (1996) The Bath ankylosing spondylitis patient global score (BAS-G). Br J Rheumatol 35:66–71

    Article  CAS  PubMed  Google Scholar 

  6. Zochling J, van der Heijde D, Burgos-Vargas R et al (2006) ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 65:442–452

    Article  CAS  PubMed  Google Scholar 

  7. Sidiropoulos PI, Hatemi G, Song IH et al (2008) Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists. Rheumatol (Oxf) 47:355–361

    Article  CAS  Google Scholar 

  8. Hetland ML (2005) DANBIO: a nationwide registry of biological therapies in Denmark. Clin Exp Rheumatol 23(5 suppl 39):S205–S207

    CAS  PubMed  Google Scholar 

  9. Altman DG, Bland JM (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307–310

    PubMed  Google Scholar 

  10. Cronstedt H, Waldner A, Stenström CH (1999) The Swedish version of the Bath ankylosing spondylitis functional index. Reliability and validity. Scand J Rheumatol Suppl 111:1–9

    Article  CAS  PubMed  Google Scholar 

  11. Waldner A, Cronstedt H, Stenström CH (1999) The Swedish version of the Bath Ankylosing Spondylitis Disease Activity Index. Reliability and validity. Scand J Rheumatol Suppl 111:10-

    Article  CAS  PubMed  Google Scholar 

  12. Pedersen OB, Hansen GO, Svendsen AJ et al (2007) Adaptation of the Bath measures on disease activity and function in ankylosing spondylitis into Danish. Scand J Rheumatol 36:22–27

    Article  CAS  PubMed  Google Scholar 

  13. Udrea G, Ciobanu C, Mihai C et al (2004) Evaluation of the Romanian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) in patients with spondyloarthropathies. Rom J Intern Med 42:199–209

    PubMed  Google Scholar 

  14. Accoc Y, Karatepe AG, Akar S et al (2005) A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 25:280–284

    Article  Google Scholar 

  15. Karatepe AG, Akkoc Y, Akar S et al (2005) The Turkish versions of the Bath Ankylosing Spondylitis and Dougados Functional Indices: reliability and validity. Rheumatol Int 25:612–618

    Article  PubMed  Google Scholar 

  16. Chatzitheodorou D, Kabitsis C, Papadopoulos NG et al (2007) Evaluation of the Greek version of the Bath Ankylosing Spondylitis Functional Index: reliability, validity, and factor analysis. Clin Exp Rheumatol 25:571–576

    CAS  PubMed  Google Scholar 

  17. El Miedany Y, Youssef S, Mehenna A (2008) Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing Spondylitis Global Score (BASG). Clin Rheumatol 27:605–612

    Article  PubMed  Google Scholar 

  18. Cardiel MH, Londono JD, Gutierrez E et al (2003) Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies. Clin Exp Rheumatol 21:451–458

    CAS  PubMed  Google Scholar 

  19. Heikkila S, Viitanen JV, Kautianen H et al (2000) Evaluation of the Finnish versions of the functional indices BASFI and DFI in spondyloarthropathy. Clin Rheumatol 19:464–469

    Article  CAS  PubMed  Google Scholar 

  20. Claudepierre P, Sibilia J, Goupille P et al (1997) Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondyloarthropathy. J Rheumatol 24:1954–1958

    CAS  PubMed  Google Scholar 

  21. Ozer HT, Sarpel T, Gulek B (2005) The Turkish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validity. Clin Rheumatol 24:123–128

    Article  PubMed  Google Scholar 

  22. Wei JC, Wong RH, Huang JH et al (2007) Evaluation of internal consistency and re-test reliability of Bath ankylosing spondylitis indices in a large cohort of adult and juvenile spondylitis patients in Taiwan. Clin Rheumatol 26:1685–1691

    Article  PubMed  Google Scholar 

  23. Dougados M, van der Linden S, Juhlin R et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34:1218–1227

    Article  CAS  PubMed  Google Scholar 

  24. Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 27:361–368

    Article  PubMed  Google Scholar 

  25. Jenkinson TR, Mallorie PA, Whitelock HC (1994) Defining spinal mobility in ankylosing spondylitis (AS): the Bath AS Metrology Index. J Rheumatol 21:694–698

    Google Scholar 

  26. Madsen OR, Hansen LB, Rytter A, Suetta C, Egsmose C (2009) The Bath metrology index as assessed by a trained and an untrained rater in patients with spondylarthropathy: a study of intra- and inter-rater agreements. Clin Rheumatol 28:35–40

    Article  CAS  PubMed  Google Scholar 

  27. Bland JM, Altman DG (1996) Statistics notes: measurement error. BMJ 313:714

    Google Scholar 

  28. Glüer CC, Blake G, Lu Y (1995) Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques. Osteoporosis Int 5:262–270

    Article  Google Scholar 

  29. Bland JM, Altman DG (1996) Statistics notes: measurement error and correlation coefficients. BMJ 313:41–42

    CAS  PubMed  Google Scholar 

  30. van der Heijde D, Dijkmans B, Geusens P et al (2005) Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). Arthritis Rheum 52:582–591

    Article  PubMed  Google Scholar 

  31. van der Heijde D, Schiff MH, Sieper J et al (2009) Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial. Ann Rheum Dis 68:922–929

    Article  PubMed  Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

  1. Department of Rheumatology and Medicine C, Copenhagen University Hospital Gentofte, Hellerup, Denmark

    Ole R. Madsen

  2. Department of Rheumatology, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark

    Anne Rytter, Lonnie B. Hansen & Charlotte Egsmose

  3. Institute of Sports Medicine, Copenhagen University Hospital Bispebjerg, and Centre of Healthy Aging, University of Copenhagen, Copenhagen, Denmark

    Charlotte Suetta

  4. Department of Rheumatology, Copenhagen University Hospital Gentofte, Niels Andersens Vej 65, DK-2900, Hellerup, Denmark

    Ole R. Madsen

Authors
  1. Ole R. Madsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne Rytter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lonnie B. Hansen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Charlotte Suetta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Charlotte Egsmose
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ole R. Madsen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Madsen, O.R., Rytter, A., Hansen, L.B. et al. Reproducibility of the Bath Ankylosing Spondylitis Indices of disease activity (BASDAI), functional status (BASFI) and overall well-being (BAS-G) in anti-tumour necrosis factor-treated spondyloarthropathy patients. Clin Rheumatol 29, 849–854 (2010). https://doi.org/10.1007/s10067-010-1407-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-010-1407-5

Keywords

Search

Navigation